Neurodegeneration in Multiple Sclerosis

In multiple sclerosis (MS), conventional magnetic resonance imaging (cMRI) has proved to be a valuable tool to increase diagnostic reliability and to monitor the efficacy of experimental treatment. However, cMRI has limited specificity and accuracy as to the most disabling aspects of the MS patholog...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Filippi, Massimo., Rovaris, Marco., Comi, Giancarlo.
Format: Electronic
Language: English
Published: Milano : Springer Milan, 2007.
Series: Topics in Neuroscience
Subjects:
Online Access: http://dx.doi.org/10.1007/978-88-470-0391-0
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03081nam a22005535i 4500
001 978-88-470-0391-0
003 DE-He213
005 20170324004532.0
007 cr nn 008mamaa
008 100301s2007 it | s |||| 0|eng d
020 |a 9788847003910  |9 978-88-470-0391-0 
024 7 |a 10.1007/978-88-470-0391-0  |2 doi 
050 4 |a RC346-429.2 
072 7 |a MJN  |2 bicssc 
072 7 |a MED056000  |2 bisacsh 
082 0 4 |a 616.8  |2 23 
245 1 0 |a Neurodegeneration in Multiple Sclerosis  |h [electronic resource] /  |c edited by Massimo Filippi, Marco Rovaris, Giancarlo Comi. 
264 1 |a Milano :  |b Springer Milan,  |c 2007. 
300 |a XI, 236 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Topics in Neuroscience 
505 0 |a Background -- Neuropathological Advances in Multiple Sclerosis -- Neurophysiology -- MRI Techniques to Assess Neurodegeneration -- Atrophy -- T1 Black Holes and Gray Matter Damage -- Magnetization Transfer Imaging -- Perfusion MR I -- Diffusion-Weighted Imaging -- Proton MR Spectroscopy -- Functional MRI -- Evaluation of MRI Outcomes -- Validation of MRI Surrogates -- Defining Responders and Non-responders -- Predictive Models in Multimodal Imaging -- Lessons from Other Neurodegenerative Diseases -- Alzheimer’s Disease -- Other Neurodegenerative Conditions -- Incorporation of Other Biomarkers -- Designing MS Trials for Neurodegeneration -- Critical Review of Existing Trials -- Design for the Next Trials of Neurodegeneration. 
520 |a In multiple sclerosis (MS), conventional magnetic resonance imaging (cMRI) has proved to be a valuable tool to increase diagnostic reliability and to monitor the efficacy of experimental treatment. However, cMRI has limited specificity and accuracy as to the most disabling aspects of the MS pathology, known to occur in and outside macroscopic lesions. Modern quantitative MR techniques have the potential to overcome the limitations of cMRI, and their application is dramatically changing our understanding of how MS causes irreversible disability. Written by world-renowned scientists, the volume is indispensable for anybody working in this field. 
650 0 |a Medicine. 
650 0 |a Neurosciences. 
650 0 |a Radiology. 
650 0 |a Neuroradiology. 
650 0 |a Nuclear medicine. 
650 0 |a Neurology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Neurology. 
650 2 4 |a Neurosciences. 
650 2 4 |a Imaging / Radiology. 
650 2 4 |a Neuroradiology. 
650 2 4 |a Nuclear Medicine. 
700 1 |a Filippi, Massimo.  |e editor. 
700 1 |a Rovaris, Marco.  |e editor. 
700 1 |a Comi, Giancarlo.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9788847003903 
830 0 |a Topics in Neuroscience 
856 4 0 |u http://dx.doi.org/10.1007/978-88-470-0391-0 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650) 
999 |c 54818  |d 54818